Gabri J. Van Der Pluijm-Van Der Sluis - Publications

Improved oncolytic and immunostimulatory activity of the spontaneous jin-3 reovirus mutant in preclinical bladder cancer models.

Journal: Molecular therapy. Oncology

Published: August 18, 2025

Anti-neoplastic effects of the antipsychotic drug penfluridol in preclinical prostate cancer models.

Journal: Frontiers in oncology

Published: August 14, 2025

Extended thromboprophylaxis in enhanced recovery after surgery for colorectal cancer: a multicentre retrospective cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 15, 2025

Key factors in shared decision making between people with osteoarthritis and physiotherapists: A narrative study using storytelling.

Journal: Patient education and counseling

Published: May 14, 2025

The challenges of evidence-based prehabilitation in a real-life context for patients preparing for colorectal surgery-a cohort study and multiple case analysis.

Journal: Perioperative medicine (London, England)

Published: June 27, 2024

Persistent subjective cognitive decline in middle age: diagnosis and treatment

Journal: Tijdschrift voor psychiatrie

Published: June 16, 2023

Facilitators and barriers to enhancing physical activity in older patients during acute hospital stay: a systematic review.

Journal: The international journal of behavioral nutrition and physical activity

Published: February 09, 2022

Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates.

Journal: Human gene therapy

Published: December 04, 2021

An exploratory first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2- and 1-week interval in patients with metastatic castration resistant prostate cancer.

Journal: Pharmacology research & perspectives

Published: May 26, 2021

Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.

Journal: Cancer gene therapy

Published: February 13, 2021

The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers.

Journal: International journal of molecular sciences

Published: January 06, 2021

Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer.

Journal: Oncogene

Published: November 09, 2020